The FADS mouse: A novel mouse model of atopic keratoconjunctivitis.

[1]  E. Takamura,et al.  Japanese guidelines for allergic conjunctival diseases 2020. , 2020, Allergology international : official journal of the Japanese Society of Allergology.

[2]  K. Izuhara,et al.  Periostin: An emerging biomarker for allergic diseases , 2019, Allergy.

[3]  J. Imura,et al.  Establishment of a Mouse Model of Atopic Dermatitis by Deleting Ikk2 in Dermal Fibroblasts. , 2019, The Journal of investigative dermatology.

[4]  H. Fujishima,et al.  The efficacy of 0.1% tacrolimus ophthalmic suspension in the treatment of severe atopic keratoconjunctivitis. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  Y. Okada,et al.  Transcriptome profiling of refractory atopic keratoconjunctivitis by RNA sequencing. , 2019, The Journal of allergy and clinical immunology.

[6]  K. Izuhara,et al.  Constitutive overexpression of periostin delays wound healing in mouse skin , 2018, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[7]  K. Nakanishi,et al.  Expression of IL-33 in ocular surface epithelium induces atopic keratoconjunctivitis with activation of group 2 innate lymphoid cells in mice , 2017, Scientific Reports.

[8]  E. Takamura,et al.  Japanese guidelines for allergic conjunctival diseases 2017. , 2017, Allergology international : official journal of the Japanese Society of Allergology.

[9]  E. Takamura,et al.  Steroid-Sparing Effect of 0.1% Tacrolimus Eye Drop for Treatment of Shield Ulcer and Corneal Epitheliopathy in Refractory Allergic Ocular Diseases. , 2016, Ophthalmology.

[10]  H. Fujishima,et al.  The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases. , 2016, The Journal of allergy and clinical immunology.

[11]  Heustein Sy,et al.  Atopic keratoconjunctivitis. , 2013, Allergy and asthma proceedings.